US Contract Manufacturing Services Industry Market Analysis The US contract manufacturing services industry is a rapidly growing market, with an estimated market size of X Million and a CAGR of 25.10%. This growth is being driven by a number of factors, including the increasing complexity of manufacturing processes, the need for greater flexibility and agility in the supply chain, and the rising costs of labor. Contract manufacturing services providers offer a range of services, including product design, engineering, prototyping, production, assembly, and testing. These services can help companies to reduce costs, improve quality, and bring products to market faster.

Key Trends and Drivers:

The key trends and drivers in the US contract manufacturing services industry include the growth of automation and digitalization, the increasing use of additive manufacturing, the rise of e-commerce, and the growing demand for customized products. Automation and digitalization are helping to improve efficiency and productivity, while additive manufacturing is making it possible to produce complex parts and products with greater flexibility. E-commerce is creating new opportunities for contract manufacturers to reach new customers, and the growing demand for customized products is driving the need for more agile and flexible manufacturing processes. Recent developments include: May 2022 - Lonza and Israel Biotech Fund Collaborated Framework Agreement to Support Biologics and Small Molecules Development and Manufacture for Portfolio Companies which Facilitate Access to Israeli Market for Lonza., July 2021 - Catalent Inc launched GPEx lightning, a next-generation cell lighting technology, and the new development would shorten the duration drug the timeline by three months.. Key drivers for this market are: Evolution of service offerings has enabled organizations to increasingly rely on contract manufacturers for their production needs, Challenges due to outsourcing of manufacturing to Asian countries has played a key role in prompting organizations to rely on local contract manufacturers. Potential restraints include: Evolution of service offerings has enabled organizations to increasingly rely on contract manufacturers for their production needs, Challenges due to outsourcing of manufacturing to Asian countries has played a key role in prompting organizations to rely on local contract manufacturers. Notable trends are: Growth of Evolution of service offerings has enabled organizations to increasingly rely on contract manufacturers for their production needs.

The Report Covers Contract Manufacturing Service Companies in US and the Market is Segmented by (Pharmaceutical, Food Processing & Manufacturing, Beverage, and Personal Care).

As of November 2023, there were around *** contract manufacturers across the United States that specialized in the production of one or multiple color cosmetics categories. That year, approximately *** manufacturers developed facial cosmetics as part of their product range. Private label vs. contract manufacturing – what are the differences? When launching a beauty brand, many smaller businesses turn to private labeling to place their products on the shelves. Private label suppliers are an affordable option because they offer a catalog of pre-existing cosmetics formulas and products that customers can sell under their own brand name and logo. In the United States, private label nail cosmetics are particularly popular among consumers. Contract manufacturing, on the other hand, allows for more flexibility and uniqueness, as brands can create their own formulas, product ranges, and packaging - without the burden of new plants or expensive equipment. Successful cosmetics brands are outsourcing product manufacturing The market for contract manufacturing of cosmetic products is thriving in the United States, and it is expected to grow worldwide. To satisfy the increasing global demand for beauty and personal care products, many companies outsource their product manufacturing and packaging to external providers, as they can process and deliver products quickly. One of the world’s leading manufacturers is Seoul-based company Cosmax, which caters to premium beauty brands like Estée Lauder and L’Oréal. The manufacturer opened its first U.S. factory in 2015.

The contract manufacturing industry is vital to countless businesses, providing the agility, expertise, and scalability that modern manufacturing demands. In an era where efficiency and specialization are critical, contract manufacturers enable companies to bring their products to market faster and often at a lower cost. This article will take an in-depth look at the key facts and trends surrounding this essential sector, explore some top contract manufacturers and provide expert guidance on choosing a contract manufacturer for your business.

Graph and download economic data for New Orders and Contracts for Plant and Equipment, Value for United States from Jan 1948 to Dec 1969 about contracts, new orders, orders, equipment, new, and USA.

Access North America Electronic Contract Manufacturing and Design Services Industry Overview which includes North America country analysis of (United States, Canada, Mexico), market split by Type, Industry Verticals, Technology

The Report Covers US Pharma Contract Manufacturing Companies and the market is segmented by Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, and Secondary Packaging).

The US Pharma Contract Manufacturing (PCM) industry is experiencing robust growth, driven by several key factors. The increasing complexity of drug development, coupled with the rising demand for specialized services like High Potency API (HPAPI) manufacturing and advanced formulations (solid, liquid, and injectable doses), is fueling outsourcing. Pharmaceutical companies are increasingly focusing on core competencies, leading to a surge in demand for contract manufacturing services across all stages – from active pharmaceutical ingredient (API) production to secondary packaging. This trend is further amplified by the growing pipeline of novel therapies, particularly biologics and advanced therapies, which often require specialized manufacturing capabilities beyond the in-house expertise of many pharmaceutical companies. The North American market, particularly the US, holds a significant share of the global PCM market, benefiting from a strong regulatory framework, a well-established infrastructure, and a large pool of skilled labor. While the overall market size is not explicitly provided, considering a global CAGR of 5% and the significant US presence, a reasonable estimate for the US market in 2025 could be in the tens of billions of dollars. This estimate is further supported by the presence of major players like Thermo Fisher Scientific (Patheon), Catalent, and Lonza, which have substantial US operations and a significant market share. The industry's growth trajectory is projected to continue throughout the forecast period (2025-2033), albeit potentially at a slightly moderated CAGR. Factors such as stringent regulatory requirements, increasing competition among contract manufacturers, and potential supply chain disruptions could act as restraints. However, the long-term outlook remains positive, fueled by ongoing innovation in drug delivery technologies, the increasing prevalence of chronic diseases requiring long-term medication, and a steady stream of new drug approvals. Segmentation within the US PCM market shows a high demand for services across all stages, with potentially faster growth in specialized areas like HPAPI and advanced formulations, reflecting the trends towards more complex and potent pharmaceuticals. Competition among established players and the emergence of new specialized contract manufacturers will likely shape the industry landscape in the coming years.
This comprehensive report delves into the dynamic landscape of the US pharma contract manufacturing industry, providing a detailed analysis of its current state and future trajectory. Covering the period from 2019 to 2033, with a base year of 2025 and a forecast period spanning 2025-2033, this research offers invaluable insights for stakeholders across the pharmaceutical value chain. The report leverages rigorous data analysis to provide a 360-degree view of this multi-billion dollar market, encompassing key players like Thermo Fisher Scientific Inc (Patheon Inc), Siegfried AG, Aenova Group, Lonza Group AG, Pfizer CentreSource (Pfizer Inc), Jubilant Life Sciences Ltd, Catalent Inc, AbbVie Contract Manufacturing, Boehringer Ingelheim Group, Recipharm AB, and Baxter Biopharma Solutions (Baxter International Inc). Key drivers for this market are: , Increasing Emphasis on Drug Discovery and Outsourcing of Manufacturing; Strong R&D Investments. Potential restraints include: Increasing Lead Time and Logistics Costs, Stringent Regulatory Requirements; Capacity Utilization Issues Affecting the Profitability of CMOs. Notable trends are: Increasing Demand of API to Witness Significant Market Growth.

Metal Contract Manufacturing Market Outlook

The global metal contract manufacturing market size was estimated at USD 142.3 billion in 2023 and is projected to reach USD 215.8 billion by 2032, growing at a CAGR of 4.7% during the forecast period. The significant growth of this market can be attributed to the rising demand for precision components and the increasing outsourcing trends among original equipment manufacturers (OEMs) to achieve cost efficiency and operational flexibility.

One of the primary growth factors for the metal contract manufacturing market is the substantial rise in demand from the automotive and aerospace sectors. These industries require highly specialized and precise components, which metal contract manufacturers can provide at a competitive cost due to economies of scale and advanced technological capabilities. The increasing complexity of products and the need for lightweight, durable materials in these sectors further drive the market's growth, as manufacturers seek to leverage the expertise of contract manufacturers to meet stringent quality and regulatory standards.

Another driving factor is the technological advancements in manufacturing processes, such as CNC machining, laser cutting, and additive manufacturing. These technologies enable contract manufacturers to produce high-quality, intricate parts with greater efficiency and precision. The integration of automation and IoT in manufacturing processes also enhances productivity and reduces the time to market for new products, making contract manufacturing an attractive option for OEMs. Additionally, the adoption of Industry 4.0 practices facilitates better supply chain management, real-time monitoring, and predictive maintenance, further propelling the market's growth.

The trend of outsourcing manufacturing activities to focus on core competencies is also significantly influencing the market. Companies across various industries are increasingly relying on contract manufacturers to handle their production needs, thereby reducing overhead costs and capital investments. This trend is particularly evident in the electronics and medical device sectors, where rapid technological advancements and frequent product launches necessitate flexible and scalable manufacturing solutions. By partnering with contract manufacturers, companies can quickly adapt to market changes and meet the demands of a competitive global market.

Regionally, the Asia Pacific region dominates the metal contract manufacturing market, driven by rapid industrialization, a large consumer base, and favorable government initiatives encouraging manufacturing activities. Countries like China, India, and Japan are major contributors to the market, owing to their robust manufacturing infrastructure and skilled labor force. North America and Europe also hold significant market shares, supported by the presence of leading aerospace, automotive, and medical device manufacturers who extensively utilize contract manufacturing services. Meanwhile, the Latin America and Middle East & Africa regions are expected to witness moderate growth, as economic diversification and industrial development initiatives gain momentum.

Service Type Analysis

The metal contract manufacturing market is segmented by service type into machining, fabrication, assembly, and others. The machining segment holds a substantial share of the market, driven by the high demand for precision machining services in industries like automotive, aerospace, and electronics. Machining services, which include CNC milling, turning, and grinding, are essential for producing high-precision parts with tight tolerances. The increasing complexity of components and the need for high-performance materials further boost the demand for advanced machining capabilities. With continuous advancements in CNC technology and automation, the machining segment is expected to maintain its dominance throughout the forecast period.

Fabrication services, which encompass processes such as welding, cutting, bending, and forming, are also a crucial part of the metal contract manufacturing market. This segment caters to industries requiring large, custom metal structures and assemblies, such as construction, industrial machinery, and heavy equipment manufacturing. The demand for fabricated metal products is driven by infrastructure development projects and the need for durable, high-strength components in various applications. The adoption of advanced fabrication techniques, such as laser cutting and robotic welding, further enhances the efficiency and quality of fabricated products, cont

The size of the U.S. Personal Care Contract Manufacturing Market market was valued at USD 3.33 billion in 2023 and is projected to reach USD 5.63 billion by 2032, with an expected CAGR of 7.8 % during the forecast period. The U. S personal care contract manufacturing market includes outsourcing of manufacturing of personal care products by companies which buy products manufactured on their behalf by third party manufacturers. Hence it focuses on serving multiple needs such as skins, hairs, and face care. Through contract manufacturing, formulation, production, packaging and labelling services are provided by an independent contractor freeing up the brand company market development and product distribution. Some notable trends are more consumers are going for natural and organic products, innovation and individuals options for customization. They are exploring sustainable strategies and creating newer products meeting the newer demands of consumers. The increase in demand for the services that are affiliated to personalized beauty solutions and the search for solutions that would lower the cost of production of beauty products. With the new trend of green and high-performance products, it is estimated that the market increases further. Recent developments include: In August 2023, Eco Lips broadened its range of organic lip care products by introducing the first-ever OTC-certified organic medicated lip balm. This innovative product is designed to provide soothing relief and protection for painful fever blisters and cold sores. The inclusion strengthens confidence in Eco Lip's offerings as well as addresses consumer demand in this category. , In April 2021, Eco Lips acquired Simply Soothing to introduce Bug Soother insect repellent to the market. This strategic acquisition was aimed at expediting the expansion of Bug Soother, a well-regarded natural bug repellent widely acknowledged by families across various states of the U.S. , In January 2021, Bright International LLC acquired Bocchi Laboratories. By combining their respective strengths, Bright International LLC and Bocchi Laboratories are poised to create one of the most diverse and comprehensive full-service beauty & personal care platforms in the North American market. This strategic move expands the range of products and services offered by the combined entity as well as enhances its overall competitiveness and market positioning. .

The report analyzes different aspects of electronics contract manufacturing (with a focus on North America), the companies involved in contract manufacturing, and identifies the areas where growth and improvement are needed. Includes forecasts through 2018.

The Contract Manufacturing Market is Segmented by Industry / End-Use Sector (Pharmaceuticals, Healthcare & Medical Devices, and Others), by Contract Type (Long-Term Strategic Partnership, and Project-Based / Short-Term), and by Geography (North America, South America, Europe, Asia-Pacific, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

US Pharmaceutical Contract Manufacturing Organization Market size was valued at USD 161.76 Billion in 2024 and is projected to reach USD 300.34 Billion by 2032, growing at a CAGR of 7.15% from 2025 to 2032.

Key Market Drivers: Expanding Drug Development Pipeline and FDA Approvals: According to the United States Food and Drug Administration (FDA), new drug applications (NDAs) grew by 32% in 2023, with 68 unique medications approved. According to the National Institutes of Health (NIH), the number of active clinical trials will reach 432,000 by 2023, with 65% requiring external manufacturing support, increasing demand for CMO services. Increasing Biologics and Complex Therapeutics Development: The FDA's Center for Biologics Evaluation and Research (CBER) announced that biologics license applications grew by 45% in 2023 over 2022. According to the National Center for Biotechnology Information (NCBI), biologics account for 38% of all pharmaceuticals in development, necessitating the specific manufacturing capabilities provided by CMOs, with investments in biologics manufacturing facilities expected to reach $12.8 billion by 2023. Cost Pressures and Manufacturing Efficiency Requirements: According to the US Department of Health and Human Services (HHS), pharmaceutical companies would invest $102 billion in R&D in 2023, with 42% outsourced to CMOs for cost efficiency. According to the Congressional Budget Office, pharmaceutical companies saved an average of 25% on costs through CMO agreements in 2023, leading to increased outsourcing of manufacturing activities.

This statistic shows the number of hair care contract manufacturers in the United States as of November 2023, by state. That year, there were ** contract manufacturers for hair care products in California.

In US Contract Manufacturing Market, Companies leverage contract manufacturers (CMOs) to reduce capital expenditure, access specialized expertise, scale rapidly, and accelerate time to market.

The USA Pharmaceutical Contract Manufacturing Market size is USD 59.85 billion in 2023, showcasing market analysis, future outlook, and top players. Explore key insights, opportunities, and challenges in the industry.

US Contract Manufacturing Services Market size was valued at USD 225.8 Billion in 2024 and is projected to reach USD 393.81 Billion by 2032, growing at a CAGR of 7.2% from 2026 to 2032.

Key Market Drivers: Increasing Demand for Outsourced Manufacturing: Companies are increasingly outsourcing production to concentrate on core strengths and cut operational costs. The North American contract manufacturing services market was valued at USD 64.5 Billion in 2024 and is expected to reach USD 101.6 Billion by 2030, increasing at a 6.8% CAGR between 2025 and 2030. Advancements in Technology: Technological advancements include the Internet of Things (IoT), artificial intelligence (AI), and Industry 4.0, which are revolutionizing the contract manufacturing industry. These developments allow for more efficient and flexible manufacturing processes, which attracts corporations to outsource production. The contract manufacturing and design services market was worth USD 565.90 Billion in 2023 and is predicted to expand to USD 1,312.70 Billion by 2032, with a 9.8% CAGR over the forecast period.

North America Pharmaceutical Contract Development and Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma] - Forecast to 2032

Overview

New York, NY – June 17, 2025 – Global Orthopedic Contract Manufacturing Market size is expected to be worth around US$ 17.6 Billion by 2034 from US$ 8.3 Billion in 2024, growing at a CAGR of 7.8% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 38.4% share with a revenue of US$ 3.2 Billion.

In 2024, the orthopedic contract manufacturing market continues to witness stable expansion, driven by the increasing demand for joint reconstruction, spinal implants, and trauma fixation devices. Contract manufacturers play a critical role in supporting orthopedic OEMs by offering services such as precision machining, additive manufacturing, forging, packaging, and regulatory support. As healthcare systems worldwide face growing orthopedic caseloads due to aging populations and a rise in sports-related injuries, outsourcing has become a strategic necessity for medical device companies seeking cost efficiency and faster time-to-market.

The market is segmented by service type into design & development, manufacturing, quality assurance, and packaging. Among these, manufacturing services remain dominant due to the complexity and customization required in producing orthopedic implants. Material-wise, titanium and stainless steel alloys continue to be widely used, while interest in bioresorbable materials and PEEK (polyether ether ketone) is rising.

North America holds the largest share of the market, supported by advanced healthcare infrastructure, high surgical volume, and a strong base of orthopedic OEMs. Meanwhile, Asia Pacific is emerging as a high-growth region, driven by increasing medical tourism, cost-effective manufacturing capabilities, and favorable government policies to support the medtech sector. As innovation in minimally invasive techniques and smart implants accelerates, contract manufacturers are expected to adopt advanced automation and digital manufacturing technologies to stay competitive.

This statistic shows the number of color cosmetics contract manufacturers in the United States as of January 2020, by state. That year, there were ** contract manufacturers for color cosmetics in New Jersey.